Cargando…
Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
INTRODUCTION: The APLICOV-PC study assessed the safety and preliminary efficacy of plitidepsin in hospitalized adult patients with COVID-19. In this follow-up study (E-APLICOV), the incidence of post-COVID-19 morbidity was evaluated and any long-term complications were characterized. METHODS: Betwee...
Autores principales: | Varona, Jose F., Landete, Pedro, Paredes, Roger, Vates, Roberto, Torralba, Miguel, Guisado-Vasco, Pablo, Porras, Lourdes, Muñoz, Patricia, Gijon, Paloma, Ancochea, Julio, Saiz, Elena, Meira, Fernanda, Jimeno, Jose M., Lopez-Martin, Jose A., Estrada, Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992643/ https://www.ncbi.nlm.nih.gov/pubmed/36909731 http://dx.doi.org/10.3389/fcimb.2023.1097809 |
Ejemplares similares
-
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
por: Varona, Jose F, et al.
Publicado: (2022) -
Plitidepsin for the management of a cancer patient infected with SARS-CoV-2 while receiving chemotherapy
por: Guisado-Vasco, P., et al.
Publicado: (2021) -
Plitidepsin for multiple myeloma
Publicado: (2019) -
Plitidepsin: design, development, and potential place in therapy
por: Alonso-Álvarez, Sara, et al.
Publicado: (2017) -
c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity
por: Muñoz-Alonso, María J., et al.
Publicado: (2013)